Effects of Growth Hormone and IGF-1 on Anabolic Signals and Stem Cell Recruitment in Human Skeletal Muscle
Status:
Recruiting
Trial end date:
2021-12-31
Target enrollment:
Participant gender:
Summary
12 adult hypopituitary patients with newly diagnosed Growth hormone (GH)-deficiency will be
studied two times. The first examinations will be performed shortly after time of diagnose
before initiation of exogenous GH treatment, where each subject will receive a single
intravenous bolus of 0.5 mg GH. The examination day will be repeated after prolonged GH
replacement therapy (>3 month after treatment initiation).